Lisata Therapeutics vs Serina Therapeutics
Lisata Therapeutics is the larger business, with $170,000 of revenue in fiscal 2025 against $130,000 for Serina Therapeutics (1.3 times as much). Serina Therapeutics grew faster (132.1% against -83.0%). Lisata Therapeutics kept more of each dollar of sales as profit: a net margin of -9756.5% against -14755.4%.
| Latest fiscal year | Lisata TherapeuticsLSTA, 2025 | Serina TherapeuticsSER, 2025 |
|---|---|---|
| Revenue | $170,000 | $130,000 |
| Revenue growth | -83.0% | 132.1% |
| Net income | −$16.6m | −$19.2m |
| Operating margin | -10711.2% | -18478.5% |
| Net margin | -9756.5% | -14755.4% |
| Return on equity | -74.7% | — |
| Free cash flow | −$16.0m | −$18.0m |
| Cash | $16.0m | $3.1m |
| Total debt | $0 | $2.9m |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 21 | 16 |
| Market value | $9.8m | $46.7m |
| Price vs our value range | — | — |
| Moat score | 5 (Weak) | 32 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 7 buys, 25 sales |